Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells

Experimental Biology and Medicine

Volumn 232, Issue 3, 2007, Pages 385-389

  Zhou, Yang ^a   Jiang, Youchun ^a   Kang, Y James ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Copper; H9c2 cells; Hypertrophy; Protein synthesis; VEGF

Indexed keywords

COPPER; HYDROGEN PEROXIDE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL CELL; ARTICLE; CELL SIZE; CELL VOLUME; COPPER DEFICIENCY; DIET; HEART MUSCLE CELL; HYPERTROPHY; NONHUMAN; NUTRITIONAL VALUE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ENLARGEMENT; CELL LINE; CELL NUCLEUS; COPPER; COPPER SULFATE; HYDROGEN PEROXIDE; MYOBLASTS; MYOCARDIUM; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 33847391553     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hart EB, Steenbock H, Waddell J, Elvehjem CA, with the cooperation of Evelyn Van Donk, Blanche MR. Iron in nutrition. VII. Copper as a supplement to iron for hemoglobin building in the rat. J Biol Chem 77:797-833, 1928.
2. Medeiros DM, Wildman REC. Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc Soc Exp Biol Med 215:299-313, 1997.
3. Nath R. Copper deficiency and heart disease: molecular basis, recent advances and current concepts. Int J Biochem Cell Biol 29:1245-1254, 1997.
4. Klevay LM. Cardiovascular disease from copper deficiency - A history. J Nutr 130:489s-492s, 2000.
5. Kang YJ, Zhou ZX, Wu H, Wang GW, Saari JT, Klein JB. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80:745-757, 2000.
6. Elsherif L, Ortines RV, Saari JT, Kang YJ. Congestive heart failure in copper-deficient mice. Exp Biol Med 228:811-817, 2003.
7. Kopp SJ, Klevay LM, Feliksik JM. Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency. Am J Physiol Heart Circ Physiol 245:H855-H866, 1983.
8. Davidson J, Medeiros DM, Hamlin RL. Cardiac ultrastructural and electrophysiological abnormalities in postweaning copper-restricted and copper-repleted rats in the absence of hypertrophy. J Nutr 122:1566-1575, 1992.
9. Li Y, Wang L, Schuschke DA, Zhou Z, Saari JT, Kang YJ. Marginal dietary copper restriction induces cardiomyopathy in rats. J Nutr 135:2130-2136, 2005.
10. Wildman REC, Hopkins R, Failla ML, Medeiros DM. Marginal copper-restriction diets produce altered cardiac ultrastructure in the rat. Proc Soc Exp Biol Med 210:43-49, 1995.
11. Medeiros DM, Shiry LJ, McCune SA. marginal copper intakes over a protracted period in genetically and nongenetically susceptible heart disease rats disturb electrocardiograms and enhance lipid deposition. Nutr Res 25:663-672, 2005.
12. Elsherif L, Wang LP, Saari JT, Kang YJ. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J Nutr 134:855-860, 2004.
13. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282:H1821-H1827, 2002.
14. Elsherif L, Jiang Y, Saari JT, Kang YJ. Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion. Exp Biol Med 229:616-622, 2004.
15. Giordano FJ, Gerber HP, Williams SP, Vanbruqqen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath AK, Huang Y, Hickey R, Dalton N, Peterson KL, Ross J Jr, Chien KR, Ferrara N. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98:5780-5785, 2001.
16. Chen QM, Tu VC, Wu YW, Bahl JJ. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch Biochem Biophys 373:242-248, 2000.
17. Rabinowitz M, Zak R. Biochemical and cellular changes in cardiac hypertrophy. Annu Rev Med 23:245-262, 1972.
18. Schaub MC, Hefti MA, Harder BA, Eppenberger HM. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75: 901-920, 1997.
19. Kang YJ, Wu HY, Saari JT. Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart. Proc Soc Exp Biol Med 223: 282-287, 2000.
20. Harris ED. A requirement for copper in angiogenesis. Nutr Rev 62:60-64, 2004.
21. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22, 1999.
22. Klevay LM, Buchet JP, Bunker VW, Clayton BE, Gibson RS, Medeiros DM, Moser-Veillon PB, Patterson KY, Taper LJ, Wolf WR. Copper in the Western diet (Belgium, Canada, U.K. and USA). In: Anke M, Meissner D, Mills CF, Eds. Trace Elements in Man and Animals-TEMA 8. Gersdorf, Germany: Verlag Media Touristik, pp207-210, 1993.
23. Pang YH, MacIntosh DL, Ryant PB. A longitudinal investigation of aggregate oral intake of copper. J Nutr 131:2171-2176, 2001.
24. Hunt CD, Meacham SL. Aluminum, boron, calcium, copper, iron, magnesium, manganese, molybdenum, phosphorus, potassium, sodium, and zinc: concentrations in common Western foods and estimated daily intakes by infants; toddlers; and male and female adolescents, adults, and seniors in the United States. J Am Diet Assoc 101:1058-1060, 2001.
25. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108-2018, 2005.
26. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47:887-893, 2006.
27. Friehs I, Margossian RE, Moran AM, Hung CD, Moses MA, del Nido PJ. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. Basic Res Cardiol 101:204-213, 2006.
28. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci U S A 97:13801-13806, 2000.
29. Lee LY, Patel SR, Hackett NR, Mack CA, Polce DR, El-Sawy T, Hachamovitch R, Zanzonico P, Sanborn TA, Parikh M, Isom OW, Crystal RG, Rosengart TK. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg 69:14-23, 2000.
30. Friehs I, Moran AM, Stamm C, Choi YH, Cowan DB, McGowan FX, del Nido PJ. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Ann Thorac Surg 77:2004-2011, 2004.